Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis (Q63432590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nezam Afdhal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Bradley Turner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Qi He

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jens Rasenack

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Leonardo Bianchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ahmed Al Tawil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ahmed Nooman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mahmoud Massoud

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Margaret James Koziel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

771-779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

Natural history of hepatitis C

18 January 2020

cites work

1 reference

7 January 2021

Epidemiology of hepatitis C

1 reference

7 January 2021

The natural history of chronic hepatitis C and what we should do about it

1 reference

7 January 2021

The natural history of hepatitis C.

1 reference

7 January 2021

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

7 January 2021

Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group

1 reference

7 January 2021

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

1 reference

7 January 2021

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

1 reference

7 January 2021

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

1 reference

7 January 2021

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

1 reference

7 January 2021

Molecular regulation of hepatic fibrogenesis

1 reference

7 January 2021

A multicentre study of the usefulness of liver biopsy in hepatitis C.

1 reference

7 January 2021

Biochemical markers of hepatic fibrosis

1 reference

7 January 2021

Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis

1 reference

7 January 2021

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology

1 reference

7 January 2021

Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma

1 reference

7 January 2021

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis

1 reference

7 January 2021

Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis

1 reference

7 January 2021

Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis

1 reference

7 January 2021

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

1 reference

7 January 2021

Urinary transforming growth factor beta1 levels in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease

1 reference

7 January 2021

Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?

1 reference

7 January 2021

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

7 January 2021

A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.

1 reference

7 January 2021

Immunologic aspects of schistosomiasis

1 reference

7 January 2021

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections

1 reference

7 January 2021

Hepatitis C virus infection in Schistosomiasis mansoni in Brazil

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

7 January 2021

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

1 reference

7 January 2021

Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon

1 reference

7 January 2021

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557547%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference